LL-37 (Cathelicidin) Dosage Guide
Complete guide to LL-37 (Cathelicidin) dosing protocols, administration methods, and safety considerations for research purposes.
Dosage Overview
Dose per Injection
500 mcg – 1.6 mg
Frequency
Once per day
Route
topical
Cycle Length
2–4 weeks
Reconstitution
Vial Size
5 mg
BAC Water
2.0 ml
Concentration
2,500 mcg/ml
Detailed Dosage Information
Research protocols vary widely.
Typical ranges
50-200mcg administered subcutaneously 2-3 times weekly.
Some protocols use higher doses for acute infections.
Administration Method
Subcutaneous injection. Can cause significant injection site reactions. Often used in conjunction with other immune-supporting protocols.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 2.5 mg/ml
Volume to inject: 0.420 ml
Syringe units: 42.0 units — fits 0.5 ml syringe
U-100 insulin syringe (100 units = 1 ml). Verify dose with a clinician before injecting.
Pre-filled with LL-37 (Cathelicidin) defaults. Adjust values as needed.
Side Effects to Monitor
Injection site pain and reactions are common. May cause flu-like symptoms, temporary fatigue, or immune activation responses.
Safety Considerations & Risks
May overstimulate immune system in autoimmune conditions. Limited human research data. Quality and purity concerns with research products.